Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 8/20 | 0.39 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.35 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.34 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.34 |
| ▸ | TTK | P33981 | 1/20 | 0.34 |
| ▸ | BTK | Q06187 | 2/20 | 0.33 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.33 |
| ▸ | PIM1 | P11309 | 1/20 | 0.33 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.33 |
| ▸ | JAK2 | O60674 | 1/20 | 0.33 |
| ▸ | JAK3 | P52333 | 1/20 | 0.33 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.33 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31458620 | 0.76 | PIM1 (0.37) | MAPK1MAPK13TTKPIM1 | |
| SCHEMBL31458619 | 0.76 | PIM1 (0.37) | MAPK1MAPK13TTKPIM1 | |
| SCHEMBL31458578 | 0.69 | CDK2 (0.44) | MAPK1PIM1 | |
| SCHEMBL31458626 | 0.68 | AHR (0.43) | MAPK1PIM1IRAK4 | |
| SCHEMBL31458604 | 0.67 | MAPK8 (0.36) | MAPK1PIM1 | |
| SCHEMBL13425969 | 0.66 | SCD (0.42) | — | |
| SCHEMBL30841980 | 0.66 | JAK1 (0.39) | BTKJAK2 | |
| SCHEMBL31264188 | 0.64 | CCRL2 (0.39) | ROCK2BTKPIM1JAK2JAK3 | |
| SCHEMBL31458748 | 0.63 | MAPK1 (0.35) | MAPK1PIM1IRAK4 | |
| SCHEMBL31264248 | 0.63 | SUV39H2 (0.39) | BTKPIM1IRAK4JAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025096061-A1 | CDK2 INHIBITORS AND USES THEREOF | ODYSSEY THERAPEUTICS, INC. (US) | 2025-05-08 | — | — | WO | disclosed |